Clinical Trial Update: Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a vaccine therapy for patients with myelodysplastic syndromes. The conditions list also includes leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED